{Reference Type}: Journal Article
{Title}: Bionano Interactions of Organosilica Nanoparticles with Myeloid Derived Immune Cells.
{Author}: Henderson E;Wilson K;Huynh G;Plebanski M;Corrie S;
{Journal}: ACS Appl Mater Interfaces
{Volume}: 16
{Issue}: 33
{Year}: 2024 Aug 21
{Factor}: 10.383
{DOI}: 10.1021/acsami.4c08415
{Abstract}: Investigating the interactions between nanomaterials and the cells they are likely to encounter in vivo is a critical aspect of designing nanomedicines for imaging and therapeutic applications. Immune cells such as dendritic cells, macrophages, and myeloid derived suppressor cells have a frontline role in the identification and removal of foreign materials from the body, with interactions shown to be heavily dependent on variables such as nanoparticle size, charge, and surface chemistry. Interactions such as cellular association or uptake of nanoparticles can lead to diminished functionality or rapid clearance from the body, making it critical to consider these interactions when designing and synthesizing nanomaterials for biomedical applications ranging from drug delivery to imaging and biosensing. We investigated the interactions between PEGylated organosilica nanoparticles and naturally endocytic immune cells grown from stem cells in murine bone marrow. Specifically, we varied the particle size from 60 nm up to 1000 nm and investigated the effects of size on immune cell association, activation, and maturation with these critical gatekeeper cells. These results will help inform future design parameters for in vitro and in vivo biomedical applications utilizing organosilica nanoparticles.